Trendingnow
Big Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026

Latest stories from Fortune
More Big TechPage 31 of 73

By Emma BurleighJanuary 17, 2026

By Jessica MathewsJanuary 16, 2026

By Fortune EditorsJanuary 16, 2026

By Jeremy Kahn and Sharon GoldmanJanuary 16, 2026

By Marco Quiroz-GutierrezJanuary 15, 2026

By Jeremy KahnJanuary 15, 2026

By Jim EdwardsJanuary 15, 2026

By Beatrice NolanJanuary 14, 2026

By Jim EdwardsJanuary 14, 2026

By Jeremy Kahn and Beatrice NolanJanuary 13, 2026

By Jake AngeloJanuary 13, 2026

By Beatrice NolanJanuary 13, 2026

By Jason MaJanuary 13, 2026

By Michael Liedtke and The Associated PressJanuary 12, 2026

By Jason MaJanuary 12, 2026

By Sydney LakeJanuary 12, 2026

By Jeffrey Sonnenfeld and Stephen HenriquesJanuary 12, 2026

By Jeran Wittenstein, Ryan Vlastelica and BloombergJanuary 11, 2026

By Jaewon Kang and BloombergJanuary 11, 2026

By Carmen Reinicke, Jeran Wittenstein and BloombergJanuary 10, 2026

By Natalie JarveyJanuary 10, 2026

By Nick LichtenbergJanuary 9, 2026

By Jake AngeloJanuary 8, 2026

By Mark DesJardineJanuary 8, 2026

By Shane GoodwinJanuary 8, 2026

By Sasha RogelbergJanuary 7, 2026
Most Popular

















